• Not structured by international agreements
• Case-by-case basis; typically public-private sector collaborations
• Legal rights to genetic resources
• Prior informed consent (owners, stakeholders)
• Rights to patent and commercialize
• Exclusivity
• 3rd party transfer options
• Duration, jurisdiction, etc.
• Benefits (benefit sharing)